Stealth BioTherapeutics (formerly Stealth Peptides), a clinical-stage biopharmaceutical company developing drug candidates for the treatment of diseases involving mitochondrial dysfunction, today announced that Travis Wilson, Chief Executive Officer, will present a corporate overview and update at the 2015 Leerink Global Healthcare Conference.
Help employers find you! Check out all the jobs and post your resume.
